# Aging Increases the Severity of Anaphylaxis Through Changes in Mast Cell Numbers and Histamine Sensitivity

Jasper B J Kamphuis, Alexia Loste, William P M Worrall, Nadine Serhan, Thomas Villeneuve, Pol André Apoil, Benjamin Trouche-estival, Laurent Guilleminault, Nicolas Gaudenzio, Laurent L Reber

<figure><img src="image_1.png" /></figure>

## To cite this version:

Jasper B J Kamphuis, Alexia Loste, William P M Worrall, Nadine Serhan, Thomas Villeneuve, et al. Aging Increases the Severity of Anaphylaxis Through Changes in Mast Cell Numbers and Histamine Sensitivity. Allergy, 2025, 80 (10), pp.2904 - 2908. 10.1111/all.16650. hal-05512165

HAL Id: hal-05512165

https://ut3-toulouseinp.hal.science/hal-05512165v1

Submitted on 16 Feb 2026

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>

Distributed under a Creative Commons CC BY 4.0 - Attribution - International License
## LETTER OPEN ACCESS

# Aging Increases the Severity of Anaphylaxis Through Changes in Mast Cell Numbers and Histamine Sensitivity

Jasper B. J. Kamphuis<fnref n="1" /> | Alexia Loste<fnref n="1" /> | William P. M. Worrall<fnref n="1" /> | Nadine Serhan<fnref n="1" /> | Thomas Villeneuve<fnref n="1" /> | Pol André Apoil<fnref n="1" />,² | Benjamin Trouche-Estival² | the IHU HealthAge INSPIRE/Open Science group | Laurent Guilleminault<fnref n="1" />,³ | Nicolas Gaudenzio<fnref n="1" />,⁴ | Laurent L. Reber<fnref n="1" />

**Correspondence:** Nicolas Gaudenzio (nicolas.gaudenzio@inserm.fr) | Laurent L. Reber (laurent.reber@inserm.fr)

**Received:** 26 February 2025 | **Revised:** 12 June 2025 | **Accepted:** 26 June 2025

**Funding:** J.B.J.K. was supported by a fellowship from the French Medical Research Foundation (FRM) (SPF202005011962). W.P.M.W. was supported by a fellowship from INSERM-Région Occitanie. L.L.R. acknowledges support from the FRM (grant #EQU202103012566), the European Research Council (ERC-2021-CO G 101043749) and the Inspire Program of the Région Occitanie/Pyrénées-Méditerranée regional government. N.G. acknowledges support from the Agence Nationale pour la Recherche (ANR) and the European Research Council (ERC-2023-COG 101124255). The INSPIRE-T study was supported by grants from the Region Occitanie/Pyrénées-Méditerranée (Reference number: 1901175), the European Regional Development Fund (ERDF) (Project number: MP0022856), the Inspire Chairs of Excellence funded by: Alzheimer Prevention in Occitania and Catalonia (APOC), EDENIS, KORIAN, Pfizer, Pierre-Fabre, and the IHU HealthAge, which received funding from the French National Research Agency (ANR) as part of the France 2030 program (reference number: ANR-23-IAHU-0011). The IHU HealthAge Open Science initiative was supported by the French National Research Agency (ANR) as part of the France 2030 program (reference number: ANR-23-IAHU-0011) and builds on the work conducted in the Data Sharing Alzheimer project.

**Keywords:** anaphylaxis | animal models | histamine | IgE | mast cells

To the Editor,

Anaphylaxis is an acute and potentially fatal systemic allergic reaction which can affect people of any age [1]. Food-induced anaphylaxis is mainly reported in children and young adults. However, as life expectancy increases, cases of food anaphylaxis are also now becoming more frequent among the geriatric population [1]. By contrast, venom- and drug-induced anaphylaxis are much more frequent in the elderly [2]. Importantly, the risk for near-fatal or fatal anaphylaxis is also markedly increased in individuals aged 60 and older [1].

It is generally accepted that food and venom anaphylaxis rely predominantly on IgE antibodies and activation of their high-affinity receptor FcεRI on the surface of tissue mast cells (MCs)

and blood basophils. Upon exposure to food or venom allergens, MC and basophil degranulation results in the release of both preformed and newly synthesized mediators, including histamine and tryptase [3]. Increased serum tryptase levels and accumulation of skin MCs with age have been suggested in humans [4, 5]. However, very few studies have focused on anaphylaxis in the elderly, and the mechanisms through which anaphylaxis severity is increased in this age group remain largely unknown. In particular, higher severity of anaphylaxis in older individuals could be due either to factors inherent to MCs (higher MC mass in the body and/or higher degree of MC activation) or to other factors (i.e., cardiovascular diseases). In this study, we aimed to identify factors in older individuals (human and mice) that could influence anaphylaxis frequency and outcome.

Jasper B.J. Kamphuis, Alexia Loste, co-first authorship.

Nicolas Gaudenzio and Laurent L. Reber co-senior authorship.

This is an open access article under the terms of the [Creative Commons Attribution-NonCommercial License](http://creativecommons.org/licenses/by-nc), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

© 2025 The Author(s). Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

<footnote n="1">¹Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM UMR1291, CNRS UMR5051, University of Toulouse, Toulouse, France | ²Institut Fédératif de Biologie, University Hospital Centre of Toulouse, Toulouse, France | ³Department of Respiratory Medicine, University Hospital Centre of Toulouse, Toulouse, France | ⁴Genoskin SAS, Toulouse, France</footnote>

<footnote>*Members are listed in the acknowledgments.</footnote>
To confirm the age-dependent increase in MC burden and ana-
phylaxis severity, we began by examining the number and dis-
tribution of MCs in 16 calf skin biopsies from healthy volunteers
from the French INSPIRE cohort. We found that individuals
aged 60 to 84years had nearly twice as many tryptase⁺ skin
MCs across the dermis than younger individuals (Figure 1a,b).
We then conducted a retrospective analysis of 165 allergic pa-
tients who had experienced anaphylaxis. For 151 of these pa-
tients, we had information on clinical severity, which ranged
from grade 1 to grade 4. We confirmed that individuals aged
60 to 92years developed more severe anaphylaxis of grade
3 and anaphylactic shock (grade 4) compared to those aged 3
to 39years (Figure 1c). We dosed baseline circulating levels of
tryptase in the blood of these individuals, as serum tryptase is
a well-established clinical biomarker directly correlated with
the number of MCs in humans. Importantly, patients with
mastocytosis, hereditary alpha tryptasemia (HαT) or other
mast cell-related syndromes were excluded from our analysis,
based on their medical records. Additionally, a pathologically

reduced renal function (< 20% remaining function) was used as
an exclusion criterion, as this can impact serum tryptase levels.
However, no patients were excluded based on this. Regrettably,
due to this being a retrospective study, we could not perform
physiological renal function measurements. Consistent with
our skin biopsy findings, individuals aged 60 to 92years ex-
hibited significantly more baseline tryptase compared to those
aged 3 to 39years (Figure 1d). Circulating levels of tryptase
after anaphylaxis (Figure 1e) as well as the delta between levels
at baseline and after anaphylaxis (Figure 1f) were significantly
higher in aged patients. Although the causes of anaphylaxis
were different in both age groups, with food-related anaphylaxis
being more frequent in younger individuals, and drug-induced
anaphylaxis more frequent in the elderly (Table S1), our data
are indicative of an age-dependent increased MC degranulation
upon anaphylaxis.

We then turned to mouse models to further phenotypically and
functionally assess the effect of aging on MCs and basophils. We

<figure><img src="image_3.png" /><figcaption>**FIGURE 1** | Mast cell density and anaphylaxis severity increase with age in humans. (a) Representative immunofluorescence staining of human tryptase (mast cell marker, yellow) in skin samples in 28-year-old and 76-year old subjects from the INSPIRE cohort. (b) Mean mast cell density in skin samples from the INSPIRE cohort, separated by age groups of 20–29 year-old, and 64–80 year-old. (c) Severity of anaphylaxis in 3–39 year-old and 60–92 year-old patients admitted to the Toulouse University Hospital. (d–f) Baseline tryptase levels (d), tryptase levels after anaphylactic shock (e), and Δ tryptase between baseline and peak tryptase levels in a cohort of patients admitted for anaphylactic shock in the Toulouse University Hospital (f), separated by age (3–39 year-old, and 60–92 year-old). Statistical analyses, unpaired two-tailed Mann–Whitney test.</figcaption></figure>
<figure><img src="image_4.png" /><figcaption>b</figcaption></figure>

<figure><img src="image_5.png" /><figcaption>c</figcaption></figure>

<figure><img src="image_6.png" /><figcaption>d</figcaption></figure>

<figure><img src="image_7.png" /><figcaption>e</figcaption></figure>

<figure><img src="image_8.png" /><figcaption>f</figcaption></figure>

<figure><img src="image_9.png" /><figcaption>g</figcaption></figure>

<figure><img src="image_10.png" /><figcaption>h</figcaption></figure>

<figure><img src="image_11.png" /><figcaption>i</figcaption></figure>

<figure><img src="image_12.png" /><figcaption>**FIGURE 2** | Mast cell density, anaphylaxis severity, and sensitivity to histamine increase with age in mice. (a) Representative toluidine blue staining for mast cells (indicated with red arrowheads) in 3 month-old (MO) and 18 MO mice, and (b) mast cell density in sections of back skin samples from 3 MO to 18 MO mice. (c) Flow cytometry measurement of CD45+, ((CD3<sup>-</sup>/CD19<sup>-</sup>, Ly6G<sup>-</sup>, CD11b<sup>-</sup>) Lin<sup>neg</sup>, CD117<sup>+</sup> mast cell numbers in peritoneal lavage fluid. (d-i) Mouse models of anaphylaxis. (d) IgE-induced passive cutaneous anaphylaxis (PCA) in mice sensitized i.d. with IgE anti-DNP in the ear skin, followed by i.v. challenge with DNP-HSA on the next day. Changes in ear thickness (Δ μm) were monitored over 1 h after challenge. (e,f) IgE-induced passive systemic anaphylaxis (PSA) in mice sensitized i.p. with IgE anti-DNP followed by i.p. challenge with DNP-HSA on the next day. Changes in body temperature (e) and survival (f) were monitored over 1 h after challenge. (g-i) Mice were challenged i.p. with ciprofloxacin (g), histamine (h) or PAF (i) and changes in body temperature were monitored over 1 h. Data are pooled from two (d-g and i) or three (h) independent experiments, error bars indicate means ± SEM, using One-Way ANOVA, with Šidák's correction for multiple comparisons, unpaired Student *t* test, or Kruskal-Wallis' test with Dunn's correction for multiple comparisons, as appropriate. MO, month-old; NS, not significant (*p* > 0.05).</figcaption></figure>

observed a clear age-dependent increase in the number of skin and peritoneal MCs in naïve C57Bl/6 mice (Figure 2a-c), associated with significantly more surface IgE levels in 18-month-old (MO) versus 3MO skin MCs (Extended Figure 1a). Similarly, basophil numbers and surface IgE levels were also increased in 18MO mice compared to 3MO mice (Extended Figure 1b,c). This increase in surface IgE likely reflected an age-dependent rise in

circulating IgE levels, as we found ~6.5-times more elevated total IgE in sera from 18MO mice versus 3MO mice (Extended Figure 1d).

We next performed in vivo anaphylaxis challenges to study the dynamics and intensity of the reaction in mice of different ages. We sensitized groups of mice ranging from 3 to 18 months
with dinitrophenyl (DNP)-specific IgE, followed by challenge with DNP to trigger passive cutaneous or systemic anaphylaxis (i.e., PCA or PSA, respectively). We observed a clear increase in ear swelling following IgE-mediated PCA in 18MO mice as compared to 3MO mice (Figure 2d). We also measured an age-dependent increase in immediate hypothermia, the main readout of PSA in mice, following systemic DNP challenge (Figure 2e). Moreover, while all 3 MO and 90% of the 6 MO mice survived, 70% of the 12 MO and all 18 MO mice died within 30 min after challenge (Figure 2f). Various drugs, including ciprofloxacin, can also directly induce MC degranulation and anaphylaxis through activation of the Mas-related G-protein coupled receptor member X2 (MRGPRX2 in human; MrgprB2 in mice) [3]. We found that the severity of ciprofloxacin-induced anaphylaxis also increased in an age-dependent manner in mice (Figure 2g).

Several factors can contribute to the increased severity of ana-
phylaxis in the elderly, including comorbidities, frailty, and
changes in vascular permeability. Histamine is considered the
main driver of MC-mediated anaphylaxis in humans and mice
[3]. We thus assessed whether aging could directly influence the
sensitivity to histamine. We found a clear age-dependent increase
in immediate hypothermia following the injection of histamine
in mice (Figure 2h). Besides histamine, platelet-activating fac-
tor (PAF) is also considered a major mediator of anaphylaxis in
mice, and potentially also in human [3]. Interestingly, we found
no difference in hypothermia following PAF injection in 3MO
versus 18MO mice (Figure 2i).

Altogether, our results demonstrate that aging increases the severity of both FcεRI- and MrgprB2-mediated anaphylaxis in mice. While multiple factors likely contribute to the increased severity of anaphylaxis in the elderly, we found clear evidence that aging increases the number of MCs in different tissues (and to a lesser extent blood basophils), which should result in a marked increase in the overall histamine pool. It is generally accepted that allergen-specific IgE levels decrease with age in humans. However, there are also indications that total IgE levels increase with age [6]. Here, we report that aging increases circulating and surface IgE levels in MCs and basophils in naïve mice born and housed in specific pathogen-free (SPF) conditions. In addition, we demonstrated that aged mice also become much more sensitive to the effects of histamine, but not to PAF, which altogether could explain, at least in part, the increase in anaphylaxis severity observed in the elderly, by increased effector cell populations and function on the one hand, as well as increased sensitivity to histamine on the other. These findings support a clinical hypothesis in which an age-dependent increase in anaphylaxis severity could result from the natural increase in MC numbers, intracellular MC mediator content, and the physiological sensitivity to histamine.

Author Contributions

J.B.J.K., A.L., W.P.M.W., N.S., T.V., P.A.A., B.T.-E. generated the data; J.B.J.K., A.L., T.V., L.G., N.G., and L.L.R. analyzed and discussed results; J.B.J.K., A.L., N.G., and L.L.R. prepared the figures and wrote the manuscript. All authors were given the opportunity to read and make amendments to the manuscript.

Acknowledgements

We are grateful to F.-E. L'Faqihi-Olive at the flow cytometry core facility of INSERM UMR1291 (Infinity, Toulouse, France) for technical assistance, the Cell Imaging Facility of UMR1291 (Infinity, Toulouse, France), and the animal facility staff of INSERM US006 (CREFRE, Toulouse, France). The members of the IHU HealthAge INSPIRE/Open Science Group are: Coordinators: Sophie Guyonnet, Bruno Vellas; Project managers: Lauréane Brigitte, Agathe Milhet; Clinical Research Assistants: Elodie Paez, Emeline Muller, Sabine Le Floch; Investigators: Catherine Takeda, Catherine Faisant, Françoise Lala, Gabor Abellan Van Kan, Zara Steinmeyer, Antoine Piau, Tony Macaron, Davide Angioni, Pierre-Jean Ousset; Nurses: Mélanie Comté, Nathalie Daniaud, Fanny Boissou-Parachaud; Biological sample collection subgroup: Marie Dorard, Bénédicte Razat, Camille Champigny, Sophie Guyonnet; IHU HealthAge Open Science group: Nicola Coley, Sophie Guyonnet, Sandrine Andrieu (contact: ihuosInspiredataaccess@chu-toulouse.fr). Catherine Takeda, Catherine Faisant, Françoise Lala, Gabor Abellan Van Kan, Zara Steinmeyer, Antoine Piau, Tony Macaron, Davide Angioni, Pierre-Jean Ousset,

Conflicts of Interest

L.L.R. is or recently was a speaker and/or advisor for and/or has re-
ceived research funding from ArgenX, Novartis, Ceva, and Neovacs,
and is an inventor on patents issued or pending relating to IgE detection
and anti-IgE therapies: EP2021/060829, EP20315224-4, WO2019197607
(A1). N.G. is (or was) collaborating, consulting, or a member of the
scientific advisory board for Genoskin (CSO, shareholder), Escent
Pharmaceuticals, Aikium, CEVA, MaxiVax, Boehringer Ingelheim,
Novartis, Sanofi, and ArgenX. The rest of the authors declare no con-
flicts of interest.

Data Availability Statement

The data that support the findings of this study are available from the
corresponding author upon reasonable request.

Jasper B. J. Kamphuis

Alexia Loste

William P. M. Worrall

Nadine Serhan

Thomas Villeneuve

Pol André Apoil

Benjamin Trouche-Estival

the IHU HealthAge INSPIRE/Open Science
groupLaurent Guilleminault

Nicolas Gaudenzio

Laurent L. Reber

References

1. M. T. Ventura, E. Boni, L. Taborda-Barata, H. Blain, and J. Bousquet, "Anaphylaxis in Elderly People," *Current Opinion in Allergy and Clinical Immunology* 22, no. 6 (2022): 435-440.

2. S. Aurich, S. Dolle-Bierke, W. Francuzik, et al., "Anaphylaxis in Elderly Patients-Data From the European Anaphylaxis Registry," *Frontiers in Immunology* 10 (2019): 750.

3. W. W. Stevens, M. Kraft, and S. C. Eisenbarth, "Recent Insights Into the Mechanisms of Anaphylaxis," *Current Opinion in Immunology* 81 (2023): 102288.

4. S. M. Pilkington, M. J. Barron, R. E. B. Watson, C. E. M. Griffiths, and S. Bulfone-Paus, "Aged Human Skin Accumulates Mast Cells With Altered Functionality That Localize to Macrophages and Vasoactive Intestinal Peptide-Positive Nerve Fibres," *British Journal of Dermatology* 180, no. 4 (2019): 849-858.

5. M. C. Slot, L. H. J. Claessen, J. A. P. Bons, P. Menheere, C. M. G. Nieuwhof, and D. de Boer, "Tryptase Reference Ranges Are
Age-Dependent in a Large Population-Based Cohort," *Allergy* 77, no. 9 (2022): 2833-2834.

6. M. De Amici and G. Ciprandi, "The Age Impact on Serum Total and Allergen-Specific IgE," *Allergy, Asthma & Immunology Research* 5, no. 3 (2013): 170-174.

**Supporting Information**

Additional supporting information can be found online in the
Supporting Information section.